Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Predicting an FDA inspection: Here’s how the CISST algorithm works

December 4, 2018 By Chris Newmarker

Lisa Wickert, IMARC Research

In the fiscal year of 2017, the Food and Drug Administration (FDA) performed over 900 inspections through the Bioresearch Monitoring (BIMO) Program. Of those 900 inspections, approximately 70% of the inspections targeted clinical sites. Without a doubt, there is some prediction about when and where the FDA will announce inspections during the course of clinical trial, both from the sponsor and the clinical sites.

So how does the FDA decide what sites to inspect? When it comes to inspections, the FDA has faced a number of growing challenges in recent years. The number of sites in a single clinical trial continues to rise. Additionally, clinical trials are becoming a more global affair with many sites located in foreign countries. With these challenges in mind, the FDA has been developing and implementing its Clinical Investigator Site Selection Tool (CISST). The primary goal of the CISST is to develop a science-based approach for site selection to ensure that even with limited resources, sites that pose the highest risk to public health are selected for inspection.

Jean Mulinde, senior policy advisor in the Office of Compliance, gave a presentation earlier this year explaining how the CISST is used to rank clinical sites by compiling data on a number of attributes submitted by sponsors to compile the “Clinsite” data set. Moreover, the FDA released a draft guidance in February 2018 outlining the electronic submission of data in standardized format for CDER (Center for Drug Evaluation and Research) to plan BIMO inspections. Overall, this data set includes both study-wide and site-specific information. At the study level, information includes data such as clinical trial type and design. At the site level, this includes information such as enrollment numbers, protocol deviation occurrences, adverse events, the Investigator track record with prior inspections, financial disclosures, and more. Once compiled, each category is then assigned a weight value and put through an extensive three-part calculation. The end result is an overall risk score, with the higher the score the more likely an inspection. The FDA can then utilize the risk score to determine if an inspection is warranted.

What does this all mean for clinical sites, sponsors, and CROs? As of right now, it is too early and there is not enough data to predict how this will change FDA inspection patterns or frequency. In the meantime, all players in a clinical trial should be prepared for a FDA audit at any time and be aware of the most common FDA violations that result in 483s and warning letters during BIMO inspections.

So ask yourself this: What strategies do you implement at the sponsor, CRO, or site level to be FDA inspection ready?

Lisa Wickert is a clinical research associate for IMARC Research, which has offices in Strongsville, Ohio, and Minnetonka, Minn.

Related Articles Read More >

A photo of former FDA official Bakul Patel
Google Health hires FDA’s chief digital health officer
FDA
FDA moves forward with Voluntary Improvement Program to bolster medical device quality
Medtronic Hugo robot-assisted surgery system
The road to a robot: Medtronic’s development process for its Hugo RAS system
iRhythm stays silent on federal grand jury subpoenas

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech